Literature DB >> 21075369

Intrauterine demise due to congenital mesoblastic nephroma in a fetus conceived by assisted reproductive technology.

Monique E De Paepe1, Svetlana Shapiro, Lawrence Young, Stephen R Carr, Fusun Gundogan.   

Abstract

OBJECTIVE: To report a case of antenatally diagnosed congenital mesoblastic nephroma in an assisted reproductive technology (ART) conception.
DESIGN: Case report.
SETTING: Tertiary care university-affiliated hospital. PATIENT(S): Fetus of 26-weeks' gestation with antenatally diagnosed large abdominal tumor. INTERVENTION(S): ART with transfer of cryopreserved embryo. MAIN OUTCOME MEASURE(S): Postmortem examination. RESULT(S): Examination revealed a congenital mesoblastic nephroma, mixed classic and cellular type, with marked intratumoral hemorrhage and associated hydrops. The marked fetal erythroblastosis was suggestive of fetal response to pronounced anemia. Intrauterine demise is attributed to fetal intratumoral hemorrhage and early nonimmune hydrops secondary to a large congenital mesoblastic nephroma. CONCLUSION(S): This is the third reported case of congenital mesoblastic nephroma in an ART conception. Whether the association between mesoblastic nephroma and ART is coincidental or causative remains to be determined.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21075369     DOI: 10.1016/j.fertnstert.2010.10.032

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

1.  Antenatally detected solid tumour of kidney.

Authors:  Shasanka Shekhar Panda; Ankur Mandelia; Devendra Kumar Gupta; Amit Singh
Journal:  BMJ Case Rep       Date:  2014-02-13

Review 2.  Prenatal Course and Sonographic Features of Congenital Mesoblastic Nephroma.

Authors:  Theera Tongsong; Watchareepohn Palangmonthip; Wisit Chankhunaphas; Suchaya Luewan
Journal:  Diagnostics (Basel)       Date:  2022-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.